These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30407693)

  • 1. Methylglyoxal as a prognostic factor in patients with chronic kidney disease.
    Tezuka Y; Nakaya I; Nakayama K; Nakayama M; Yahata M; Soma J
    Nephrology (Carlton); 2019 Sep; 24(9):943-950. PubMed ID: 30407693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Is the serum concentration of pentosidine a predictor of cardiovascular events in patients with type 2 diabetes and kidney disease?].
    Busch M; Franke S; Stein G; Wolf G;
    Dtsch Med Wochenschr; 2007 Sep; 132(36):1810-4. PubMed ID: 17726651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Association of dp-ucMGP with Cardiovascular Morbidity and Decreased Renal Function in Diabetic Chronic Kidney Disease.
    Roumeliotis S; Roumeliotis A; Stamou A; Leivaditis K; Kantartzi K; Panagoutsos S; Liakopoulos V
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32839405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease.
    Machowska A; Sun J; Qureshi AR; Isoyama N; Leurs P; Anderstam B; Heimburger O; Barany P; Stenvinkel P; Lindholm B
    PLoS One; 2016; 11(10):e0163826. PubMed ID: 27701453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
    Galsgaard J; Persson F; Hansen TW; Jorsal A; Tarnow L; Parving HH; Rossing P
    Kidney Int; 2017 Nov; 92(5):1242-1248. PubMed ID: 28712855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum N-terminal Pro-brain Natriuretic Peptide Level is Associated with the Development of Chronic Kidney Diseases in Patients with Type 2 Diabetes.
    Sawada R; Hashimoto Y; Senmaru T; Tanaka M; Ushigome E; Yamazaki M; Fukui M
    Endocr Metab Immune Disord Drug Targets; 2018; 18(6):590-595. PubMed ID: 29697035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Serum Uromodulin with Death, Cardiovascular Events, and Kidney Failure in CKD.
    Steubl D; Schneider MP; Meiselbach H; Nadal J; Schmid MC; Saritas T; Krane V; Sommerer C; Baid-Agrawal S; Voelkl J; Kotsis F; Köttgen A; Eckardt KU; Scherberich JE;
    Clin J Am Soc Nephrol; 2020 May; 15(5):616-624. PubMed ID: 32291270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy.
    Suliman ME; Heimbürger O; Bárány P; Anderstam B; Pecoits-Filho R; Rodríguez Ayala E; Qureshi AR; Fehrman-Ekholm I; Lindholm B; Stenvinkel P
    J Am Soc Nephrol; 2003 Jun; 14(6):1614-22. PubMed ID: 12761263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low white blood cell count is independently associated with chronic kidney disease progression in the elderly: the CKD-ROUTE study.
    Arai Y; Kanda E; Iimori S; Naito S; Noda Y; Sasaki S; Sohara E; Okado T; Rai T; Uchida S
    Clin Exp Nephrol; 2018 Apr; 22(2):291-298. PubMed ID: 28699033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of proteinuria and glomerular filtration rate on Taiwanese patients with diabetes mellitus and advanced chronic kidney disease: a single center experience.
    Chen PM; Wada T; Chiang CK
    Clin Exp Nephrol; 2017 Apr; 21(2):307-315. PubMed ID: 27339442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
    Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
    Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
    Busch M; Franke S; Wolf G; Brandstädt A; Ott U; Gerth J; Hunsicker LG; Stein G;
    Am J Kidney Dis; 2006 Oct; 48(4):571-9. PubMed ID: 16997053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating renalase predicts all-cause mortality and renal outcomes in patients with advanced chronic kidney disease.
    Baek SH; Cha RH; Kang SW; Park CW; Cha DR; Kim SG; Yoon SA; Kim S; Han SY; Park JH; Chang JH; Lim CS; Kim YS; Na KY
    Korean J Intern Med; 2019 Jul; 34(4):858-866. PubMed ID: 29172403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical prediction models for progression of chronic kidney disease to end-stage kidney failure under pre-dialysis nephrology care: results from the Chronic Kidney Disease Japan Cohort Study.
    Hasegawa T; Sakamaki K; Koiwa F; Akizawa T; Hishida A;
    Clin Exp Nephrol; 2019 Feb; 23(2):189-198. PubMed ID: 30069609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of advanced glycation end products and carbonyl compounds in patients with different conditions of oxidative stress.
    Lapolla A; Reitano R; Seraglia R; Sartore G; Ragazzi E; Traldi P
    Mol Nutr Food Res; 2005 Jul; 49(7):685-90. PubMed ID: 15926142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High serum level of pentosidine, an advanced glycation end product (AGE), is a risk factor of patients with heart failure.
    Koyama Y; Takeishi Y; Arimoto T; Niizeki T; Shishido T; Takahashi H; Nozaki N; Hirono O; Tsunoda Y; Nitobe J; Watanabe T; Kubota I
    J Card Fail; 2007 Apr; 13(3):199-206. PubMed ID: 17448417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma pentosidine and total homocysteine levels in relation to change in common carotid intima-media area in the first year of dialysis therapy.
    Suliman ME; Stenvinkel P; Jogestrand T; Maruyama Y; Qureshi AR; Bárány P; Heimbürger O; Lindholm B
    Clin Nephrol; 2006 Dec; 66(6):418-25. PubMed ID: 17176913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy.
    Theilade S; Lajer M; Jorsal A; Tarnow L; Parving HH; Rossing P
    Diabet Med; 2012 Mar; 29(3):337-44. PubMed ID: 21988672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of HbA
    Lee MY; Huang JC; Chen SC; Chiou HC; Wu PY
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30567403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.
    Munoz Mendoza J; Isakova T; Cai X; Bayes LY; Faul C; Scialla JJ; Lash JP; Chen J; He J; Navaneethan S; Negrea L; Rosas SE; Kretzler M; Nessel L; Xie D; Anderson AH; Raj DS; Wolf M;
    Kidney Int; 2017 Mar; 91(3):711-719. PubMed ID: 28017325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.